Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2008) 15 P336

SFEBES2008 Poster Presentations Thyroid (68 abstracts)

Effects of dietary soy phytoestrogens on thyroid function and insulin resistance in patients with subclinical hypothyroidism: a double blind crossover study

Thozhukat Sathyapalan 1 , Alireza M Manuchehri 1 , Natalie J Thatcher 2 , Don B Clarke 3 , Alan S Rigby 4 , Eric S Kilpatrick 5 , Tom Chapman 6 , Anthony S Lloyd 3 & Stephen L Atkin 1


1Department of Diabetes and Endocrinology, University of Hull, Hull, UK; 2Food Standards Agency, London, UK; 3Food Safety Group, Department for Environment, Food and Rural Affairs, Sand Hutton, York, UK; 4Department of Academic Cardiology, University of Hull, Hull, UK; 5Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, UK; 6Essential Nutrition Ltd, Brough, UK.


Soy phytoestrogens (PE) have been shown to improve insulin resistance and lipids but may adversely affect thyroid function.

Objective: To determine the effects of soy PE on thyroid function, insulin resistance and lipid parameters in patients with subclinical hypothyroidism.

Design: A randomised, double-blind, crossover study was undertaken involving 60 patients with subclinical hypothyroidism. Patients were randomly assigned to either a low dose isoflavone (30 g of soy protein with 2 mg soy isoflavones) or a high dose isoflavone (30 g of soy protein with 16 mg soy isoflavones) supplement for 8 weeks, with 8-week wash out period, before crossover.

Main outcome measures: Changes in thyroid function tests, glucose, insulin (HOMA-IR), lipid profile, hsCRP, and plasma PE before and after treatment with low dose/high dose PE were measured.

Results: There was significant improvement in insulin resistance after 16 mg isoflavone phase (mean±S.D.) (HOMA-IR 5.11±12.2 vs 4.2±9.9 (P value 0.02) 95% CI 0.12–1.63) but no changes after 2 mg isoflavone phase. There were no changes in fT4 and TSH before or after both phases. However, the fT3 values were higher after the initial 16 mg then 2 mg isoflavone treatment (mean±S.D.) (4.11±0.62 vs 4.56±0.65 pmol/l P value <0.01), but not the converse. There were no changes seen in the lipid profiles or hsCRP.

Conclusion: High (16 mg) levels of dietary PE have a significant effect on reducing insulin resistance, but do not affect thyroid function clinically in patients with subclinical hypothyroidism that are iodine replete.

Article tools

My recent searches

No recent searches.